Latest Posts

Steven Grover, PhD awarded a CSL Behring Prof Heimburger Award Congratulations to Steven Grover, PhD, a postdoctoral fellow in the laboratory of Nigel Mackman, PhD, who has been awarded a 2021 Prof Heimburger Award from CSL Behring. This award will provide research support for his project “Evaluating the anticoagulant activity...

Congratulations to Steven Grover, PhD, a postdoctoral fellow in the laboratory of Nigel Mackman, PhD, who has been awarded a Journal of Thrombosis and Haemostasis Editors Award for his recent publication “Model‐dependent contributions of FXII and FXI to venous thrombosis in mice”. The award consists of a certificate, to be presented at the JTH Editors...

Dr. Alisa Wolberg, Scientific Co-Chair of the American Society of Hematology 2020 meeting, was interviewed about abstracts selected for the Best of ASH for the podcast “Blood & Cancer”. The episode is available at this link, and can be accessed via any platform you use to listen to podcasts. Alisa...

A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Authors: Giang N. Nguyen, John K. Everett, Samita Kafle, Aoife M. Roche, Hayley E. Raymond, Jacob Leiby, Christian Wood, Charles-Antoine Assenmacher, Elizabeth P. Merricks, C. Tyler Long, Haig H. Kazazian, Timothy...

Congratulations to Erica Sparkenbaugh, Assistant Professor in the UNC Department of Medicine Hematology, and member of the Blood Research Center.  She has been awarded a five year, $2 million R01 grant from NIH-NHLBI beginning January 2021. The goal of this project is to evaluate whether activation of beneficial PAR1 signaling...

Improving Immunizations in Patients with Non-Malignant Hematological Disorders Receiving Immunosuppressive Therapy article Based on research findings of Drs. Malpica and Moll Read article, ASH invited Dr. Moll to moderate and Dr. Malpic to present at an  education session on “Preventing Infections when treating non-malignant hematology disorders” at the annual ASH...

COVID-19 is associated with derangements in biomarkers of coagulation and endothelial cell function and has been likened to abnormalities seen in sepsis. Emma Bouck and Alisa Wolberg, PhD collaborated with investigators at the University of Utah to show that both COVID-19 and sepsis are associated with activation of mechanisms that...

My group collaborates with other BRC faculty on several disease-oriented projects. Although my expertise is primarily in the development and implementation of coagulation assays in human blood, many of our projects include both human and mouse components. These include studies on the vascular biology of sickle cell disease (with Rafal...

Dr. Abajas’ primary clinical and research interests are in hemostasis and thrombosis.

Research in the Aleman Lab is centered on basic mechanisms regulating erythropoiesis in health and disease. Differentiation of hematopoietic stem cells down the erythroid track requires coordinated gene expression, including RNA regulation, and accumulation of iron for hemoglobin production. Our current work focuses on a family of bifunctional proteins (poly...

As a member of the UNC Blood Research Center, we are able to interact and collaborate with experts in blood coagulation and platelet biology. My lab is especially interested in investigating the contribution of the coagulation and platelets to anti-viral immune responses. Furthermore, in a collaborative effort with clinical experts...

The Bahnson Research Group studies Redox Biology in Cardiovascular Disease and the development of targeted nanocarriers to deliver therapeutics.